[HTML][HTML] Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study

E Alagoz, M Saucke, P Balasubramanian… - Allergy, Asthma & …, 2023 - Springer
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

[HTML][HTML] Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study

E Alagoz, M Saucke… - Allergy, Asthma …, 2023 - aacijournal.biomedcentral.com
Penicillin allergy is the most commonly reported drug allergy in the US. Despite evidence
demonstrating that up to 90% of labels are incorrect, scalable interventions are not well …

Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.

E Alagoz, M Saucke, P Balasubramanian… - Allergy, Asthma, and …, 2023 - europepmc.org
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study

E Alagoz, M Saucke… - … : official journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study

E Alagoz, M Saucke… - Allergy, Asthma …, 2023 - search.proquest.com
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

[PDF][PDF] Barriers to Penicillin Allergy De-Labeling in the Inpatient and Outpatient Settings: A Qualitative Study

E Alagoz, M Saucke, P Balasubramanian, P Lata… - academia.edu
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

Barriers to Penicillin Allergy De-Labeling in the Inpatient and Outpatient Settings: A Qualitative Study

E Alagoz, M Saucke, P Balasubramanian, P Lata… - 2023 - researchsquare.com
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.

E Alagoz, M Saucke… - Allergy, Asthma & …, 2023 - search.ebscohost.com
Background: Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

[HTML][HTML] Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study

E Alagoz, M Saucke, P Balasubramanian… - Allergy, Asthma, and …, 2023 - ncbi.nlm.nih.gov
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …

Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.

E Alagoz, M Saucke, P Balasubramanian… - Allergy, Asthma, and …, 2023 - europepmc.org
Background Penicillin allergy is the most commonly reported drug allergy in the US. Despite
evidence demonstrating that up to 90% of labels are incorrect, scalable interventions are not …